NEW YORK, Oct. 21, 2016 -- Guggenheim Investments, the global asset management and investment advisory business of Guggenheim Partners, today announced it will complete transition of underlying indices for Guggenheim Defensive Equity ETF (DEF) and Guggenheim Insider Sentiment ETF (NFO) effective October 24, 2016.
The names and ticker symbols of both ETFs remain the same.
| Ticker | Name | New Index | Previous Index |
| DEF | Guggenheim Defensive Equity ETF | Guggenheim Defensive Equity Index | Sabrient Defensive Equity Index |
| NFO | Guggenheim Insider Sentiment ETF | Nasdaq US Insider Sentiment Index | Sabrient Insider Sentiment Index |
For more information, please visit http://www.guggenheiminvestments.com/etf or call 888.WHY.ETFs to speak to a representative.
About Guggenheim Investments
Guggenheim Investments is the global asset management and investment advisory division of Guggenheim Partners, with $202 billion1 in assets across fixed income, equity, and alternative strategies. We focus on the return and risk needs of insurance companies, corporate and public pension funds, sovereign wealth funds, endowments and foundations, consultants, wealth managers, and high-net-worth investors. Our 275+ investment professionals perform rigorous research to understand market trends and identify undervalued opportunities in areas that are often complex and underfollowed. This approach to investment management has enabled us to deliver innovative strategies providing diversification and attractive long-term results.
1Guggenheim Investments total asset figure is as of 06.30.2016. The assets include leverage of $11.4bn for assets under management and $0.5bn for assets for which we provide administrative services. Guggenheim Investments represents the following affiliated investment management businesses: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Real Estate, LLC, Transparent Value Advisors, LLC, GS GAMMA Advisors, LLC, Guggenheim Partners Europe Limited and Guggenheim Partners India Management.
RISK CONSIDERATIONS
Stock markets can be volatile. Investments in securities of small and medium capitalization companies may involve greater risk of loss and more abrupt fluctuations in market price than investments in larger companies. DEF seeks to track a quantitative strategy index, created by a proprietary model, and its success depends on the effectiveness of the model. As a result, the fund could have a lower return than if it were managed using a fundamental investment strategy that did not incorporate quantitative analysis.
Index Disclaimer: Guggenheim Defensive Equity Index is a trademark of Accretive Asset Management LLC. Accretive Asset Management, LLC is an affiliate of Guggenheim Investments. Nasdaq and “Nasdaq US Insider Sentiment” are trademarks of Nasdaq, Inc. (which with its affiliates is referred to as the “Corporations”) and are licensed for use by Guggenheim Investments. The fund has not been passed on by the Corporations as to their legality or suitability. Guggenheim funds are not issued, endorsed, sold, or promoted by the Corporations. THE CORPORATIONS MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO GUGGENHEIM INVESTMENTS FUNDS.
Read a fund’s prospectus and summary prospectus (if available) carefully before investing. It contains the fund’s investment objectives, risks, charges, expenses and other information, which should be considered carefully before investing. Obtain a prospectus and summary prospectus (if available) at www.guggenheiminvestments.com or call 800.820.0888.
The referenced funds are distributed by Guggenheim Funds Distributors, LLC. Guggenheim Investments represents the investment management businesses of Guggenheim Partners (“Guggenheim”), which includes Guggenheim Funds Investment Advisors, LLC ("GFIA"), the investment advisor to the referenced funds. Guggenheim Funds Distributors, LLC is affiliated with Guggenheim and GFIA.
PR-NFODEF
Media Contact Ivy McLemore Guggenheim Partners 212.518.9859 [email protected]


Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Italy Fines Apple €98.6 Million Over App Store Dominance
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 



